Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    nct01461837
Show Display Options
Rank Status Study
1 Recruiting Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease
Condition: Sickle Cell Disease
Intervention: Drug: CD34 selected T-cell depleted allogeneic SCT

Indicates status has not been verified in more than two years